Find uplifting stories about heroes, innovations, and solutions
3 results for "disease-modifying therapy"
Health Canada has authorized Kisunla, a breakthrough treatment that slows early Alzheimer's progression by 22% and can be stopped once brain plaques clear. Over 770,000 Canadians living with Alzheimer's now have access to the first disease-modifying therapy that targets the root cause of memory loss.
A newly approved Alzheimer's treatment in Malaysia can slow disease progression by more than eight years, giving patients precious extra time with their independence and loved ones. Unlike previous treatments that only managed symptoms, lecanemab actually changes how the disease progresses.
A groundbreaking treatment could help children with Dravet syndrome not just reduce seizures, but actually improve cognitive development and daily living skills. For the first time, families facing this devastating genetic condition have hope for a disease-modifying therapy.